Federal award
INO THERAPEUTICS LLC
W81K0221F0023
Contract
Obligated and Ceiling
- Obligated (net)
- $232,772.44
- Ceiling (potential value, not spending)
- $232,772.44
- Current value
- $232,772.44
- Gross positive obligations
- $534,906.25
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- INO THERAPEUTICS LLC · XXQHL619FUN6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- INO THERAPEUTICS LLC · XXQHL619FUN6
- Awarding agency
- Department of War · sub-agency 2100 · office W81K02
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- W81K0221F0023
- Parent vehicle (IDV PIID)
- V797D60737
- Award type code
- C
- Actions
- 15 · Dec 22, 2020 to May 21, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History15
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 21, 2025 | FY2025 | P00014 | B | −$62,746.22 | — |
| Nov 7, 2024 | FY2025 | P00013 | C | $125,655.00 | — |
| Aug 19, 2024 | FY2024 | P00012 | M | −$60,000.00 | — |
| Jun 26, 2024 | FY2024 | P00011 | G | $0.00 | — |
| Nov 16, 2023 | FY2024 | P00010 | C | $125,655.00 | — |
| May 17, 2023 | FY2023 | P00009 | G | $0.00 | — |
| May 12, 2023 | FY2023 | P00008 | B | −$135,572.08 | — |
| Mar 15, 2023 | FY2023 | P00007 | B | $63,700.00 | — |
| Apr 27, 2022 | FY2022 | P00006 | G | $0.00 | — |
| Apr 11, 2022 | FY2022 | P00005 | B | −$43,815.51 | — |
| Oct 18, 2021 | FY2022 | P00004 | C | $125,655.00 | — |
| May 14, 2021 | FY2021 | P00003 | G | $0.00 | — |
| Mar 2, 2021 | FY2021 | P00002 | B | $0.00 | — |
| Jan 11, 2021 | FY2021 | P00001 | C | $94,241.25 | — |
| Dec 22, 2020 | FY2021 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.